Confirmation of mutations in MMR and EPCAM deletions (EPCAM-MSH2) (Lynch syndrome) in BRCA1/2 (HBss/HBOC/HOC) and in PTEN (Cowden’s syndrome) should result in genetic testing among relatives to identify carriers of the germline mutation. This evidence concerns the gene MSH2 and Lynch syndrome.